SAS Output

18-JUN-2018 6:10

GI ACCRUAL REPORT - Open and Recently Closed Studies

The REPORT Procedure

Detailed and/or summarized report

Table 1

SWOG/
Support
STUDY R
E
G
O
P
E
N
ARM ACCR.
GOAL
TOTAL
REGS.
REGS.
LAST
12
Month
REGS.
LAST
6
Month
REGS.
LAST
3
Month
REGS.
LAST
30
DAYS
REGS.
LAST
7
DAYS
DATE OF
FIRST
REG.
# of
ACT.
INSTs
# of
CURR
IRBs
SWOG S1613-mCRC, Adv/Met, TP vs CETIRI 1 Y 0 Screening 130 36 36 34 25 9 1 11/27/2017   119
            36 36 34 25 9 1      
 
    2 Y 1 Trastuzumab + Pertuzumab 130 4 4 4 3 2 1 11/27/2017    
        2 Cetuximab + Irinotecan   2 2 2 2 1 0      
            6 6 6 5 3 1      
 
Yes A021502-Colon, Stg III, Chemo +/- Atezol, ATOMIC 1 E Total Registrations   4 4 4 4 0 0 03/23/2018   27
            4 4 4 4 0 0      
 
  N1048-Rectal,LocalAdv,ChemoRT+/-FOLFOX 1 E Total Registrations   151 32 18 6 2 1 06/05/2013   162
            151 32 18 6 2 1      
 
  R0848-Panc, Adj, Erlotinib v ChemoRT 1 E Total Registrations   20 0 0 0 0 0 01/24/2011   137
            20 0 0 0 0 0      
 
    2 E Total Registrations   5 0 0 0 0 0 01/24/2011    
            5 0 0 0 0 0      
 
No A021501-Adeno Panc,Borderline Resect,Chemo vs ChemoRT 0 E Total Registrations   18 16 6 3 0 0 05/01/2017   89
            18 16 6 3 0 0      
 
    1 E Total Registrations   15 13 5 3 0 0 05/01/2017    
            15 13 5 3 0 0      
 
  EA2142-GI NEC, Adv G3, EP vs TMZ + CAP 1 E Total Registrations   4 3 0 0 0 0 07/14/2016 182 74
            4 3 0 0 0 0      
 
  NRGGI002-Rectal, Ph II, Sensitization using TNT 1 E Total Registrations   6 4 2 0 0 0 02/21/2017 325 140
            6 4 2 0 0 0      
 
  NRGGI004-Colorectal, Stg IV, dMMR Immuno-Therapy 1 E Total Registrations   1 1 1 1 0 0 04/18/2018   18
            1 1 1 1 0 0      
 

18-JUN-2018 6:10

GI Open Studies with No Registrations

The REPORT Procedure

Detailed and/or summarized report

Table 1

Study Registration/Phase Open Date
S1613 mCRC, Adv/Met, TP vs CETIRI 3 Crossover 09-Oct-17